| Financial Year |
March 31 2023 |
| Monetary Funds |
2,053,490,591.75 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
18,523,419.49 |
| Accounts Receivable |
1,702,029,514.21 |
| Advances to Suppliers |
5,460,255.38 |
| Other Receivables |
66,555,538.31 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,994,548,738.81 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
340,808,522.93 |
| Total Current Assets |
6,181,416,580.88 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
558,123,647.23 |
| Investment Properties |
-- |
| Fixed Assetes |
2,421,863,250.50 |
| Under-construction Projects |
276,076,252.68 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
297,339,371.92 |
| R&D expenses |
114,036,230.06 |
| Goodwill |
545,465,220.56 |
| Long-Term Deferred and Prepaid Expenses |
302,979,984.34 |
| Deferred Income Tax Assets |
99,514,278.07 |
| Other Non-Current Assets |
281,592,007.65 |
| Sub-Total of Non-Current Assets |
5,064,065,243.90 |
| Total Assets |
11,245,481,824.78 |
| Short-Term Loans |
1,182,366,950.18 |
| Trading Financial liabilities |
7,388,884.04 |
| Notes Payable |
409,183,629.16 |
| Accounts Payable |
947,956,161.39 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
143,988,638.04 |
| Taxes Payable |
20,165,527.45 |
| Interest Payable |
958,571.45 |
| Dividend Payable |
-- |
| Other payables |
96,887,008.10 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
498,242,684.54 |
| Other Current Liabilities |
58,121.30 |
| Sub-Total of Current Liabilities |
3,342,789,776.35 |
| Long-term Loans |
975,557,120.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
2,580,784.68 |
| Deferred Income Tax Liabilities |
2,256,683.62 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,113,637,047.99 |
| Total Liabilities |
4,456,426,824.34 |
| Paid-In Capital(Or Share Stock) |
967,568,638.00 |
| Capital Surplus |
330,659,341.59 |
| Surplus Reserve |
340,447,529.96 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
5,085,010,085.35 |
| Minority Stockholder's Interest |
65,721,936.81 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
6,723,333,063.63 |
| Owner's Equity（Stockholder's Equity） |
6,789,055,000.44 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
11,245,481,824.78 |
